|
Below is an in-depth analysis and side-by-side comparison of Primary Dentist vs Baxter International including start-up costs and fees, business experience requirements, training & support and financing options.
Start-Up Costs and Fees |
||
Investment | $208,672 - $479,172 | $54,450 - $67,450 |
Franchise Fee | $29,997 | $20,000 |
Royalty Fee | 6% | 5% |
Advertising Fee | 6% | - |
Year Founded | - | - |
Year Franchised | - | - |
Term Of Agreement | - | - |
Term Of Agreement | - | - |
Renewal Fee | - | - |
Business Experience Requirements |
||
Experience | To ensure that our franchisees will be able to qualify with both lenders and landlords, we require that potential franchisees have at least $150,000 in liquid capital and a $200,000 net worth. | - |
Financing Options |
||
In-House/3rd Party | In-House/3rd Party | |
Franchise Fees | -/- | -/- |
Start-up Costs | -/- | -/- |
Equipment | -/- | -/- |
Inventory | -/- | -/- |
Receivables | -/- | -/- |
Payroll | -/- | -/- |
Training & Support |
||
Training | - | - |
Support | - | - |
Marketing | - | - |
Operations | - | - |
Expansion Plans |
||
US Expansion | Yes | - |
Canada Expansion | - | - |
International Expansion | - | - |
NO LONGER FRANCHISING
We have the answer to building a dental practice, and will provide you with marketing and advertising programs to bring new patients in the door. Our dental model outperforms the average dentist by a substantial multiple. Join with an industry leader to improve your results. There is no need to be overburdened by office systems and procedures; we have researched and proven the best office systems and software. For dental equipment, we will help arrange financing and discounts.
Baxter gives an expansive arrangement of fundamental renal and clinic items, including home, intense and in-focus dialysis; clean IV arrangements; implantation frameworks and gadgets; parenteral sustenance; biosurgery items and sedatives; and drug store mechanization, programming and administrations. The organization's worldwide impression and the basic way of its items and administrations assume a key part in growing access to medicinal services in rising and created nations. Baxter's representatives worldwide are expanding upon the organization's rich legacy of therapeutic leaps forward to propel the up and coming era of social insurance developments that empower tolerant care.